EFDID: 587237EFD: View Filing

Issuer: Sensei Biotherapeutics, Inc. (0001829802) - D

Accession: 0001829802-26-000001 (XMLRaw Data) (EDGAREDGAR Files) (Form DForm D)

EDGAR: Issuer Information
  • CIK:
    0001829802
  • Entity Name:
    Sensei Biotherapeutics, Inc.
  • Entity Type:
    Corporation
  • Jurisdiction:
    DELAWARE
  • Year of Inc:
    Over 5 years ago
  • Address:
    1405 RESEARCH BLVD, SUITE 125
    ROCKVILLE, MD 20850
  • Persons:
    Related Persons 7
    Christopher Gerry
    Executive Officer, Director
    Josiah Craver
    Executive Officer
    Tom Ricks
    Director
    Anand Kiran Parikh
    Executive Officer, Director
    Phillip B. Donenberg
    Director
    Bob Holmen
    Director
    Kristian Humer
    Director
EDGAR: Offering Information
  • Accession Date:
    03/04/2026
  • First Sale Date:
    02/17/2026
  • Offering Amount:
    $348,906,500
  • Amount Sold:
    $348,906,500
  • Exemptions:
    Rule 506
  • Security Type(s):
    Equity
EFD: Current State Notices
View Notices

Notices found in EFD

Filed:CA, CT, GA, IL, KS, MA, MN, MO, NV, NY, OR, PA, TX, VA, WA
EDGAR: Sales Compensation Recipient Information
RecipientCRDBroker DealerBD CRDStates
Leerink Partners 39011 None None All States
EDGAR: Signatures
IssuerSignatureSigner NameTitleSignatureDate
Sensei Biotherapeutics, Inc./s/ Christopher GerryChristopher GerryPresident and Principal Executive Officer2026-03-04